Department of Pediatrics, Tongji Hospital, Tongji Medical College, Huazhong University of Science & Technology, Wuhan, 430030, Hubei Province, China.
J Nephrol. 2023 Jun;36(5):1415-1423. doi: 10.1007/s40620-023-01570-7. Epub 2023 Apr 25.
Alport syndrome is caused by COL4A3, COL4A4, or COL4A5 gene mutations. The present study aims to compare the clinicopathological features, gene mutations, and outcome of Chinese children with different forms of Alport syndrome.
One hundred twenty-eight children from 126 families diagnosed with Alport syndrome through pathological and genetic examination between 2003 and 2021 were included in this single-center retrospective study. The laboratory and clinicopathological features of the patients with different inheritance patterns were analyzed. The patients were followed-up for disease progression and phenotype-genotype correlation.
Of the 126 Alport syndrome families, X-linked forms accounted for 77.0%, autosomal recessive for 11.9%, autosomal dominant for 7.1%, and digenic for 4.0%. Among the patients, 59.4% were males and 40.6% were females. Altogether, 114 different mutations were identified in 101 patients from 99 families by whole-exome sequencing, of which 68 have not been previously reported. The most prevalent type of mutation was glycine substitution, which was identified in 52.1%, 36.7%, and 60% of the patients with X-linked Alport syndrome, autosomal recessive and autosomal dominant Alport syndrome, respectively. At the end of a median follow up of 3.3 (1.8-6.3) years, Kaplan-Meier curves showed kidney survival was significantly lower in autosomal recessive compared to X-linked Alport syndrome (P = 0.004). Pediatric patients with Alport syndrome seldom presented extrarenal involvement.
X-linked Alport syndrome is the most frequent form found in this cohort. Progression was more rapid in autosmal recessive than in X-linked Alport syndrome.
Alport 综合征是由 COL4A3、COL4A4 或 COL4A5 基因突变引起的。本研究旨在比较不同形式的 Alport 综合征中国儿童的临床病理特征、基因突变和结局。
本研究为单中心回顾性研究,纳入了 2003 年至 2021 年间通过病理和基因检查诊断为 Alport 综合征的 126 个家系的 128 名儿童。分析了不同遗传模式患者的实验室和临床病理特征。对患者进行了疾病进展和表型-基因型相关性随访。
在 126 个 Alport 综合征家系中,X 连锁形式占 77.0%,常染色体隐性遗传占 11.9%,常染色体显性遗传占 7.1%,双基因遗传占 4.0%。患者中,男性占 59.4%,女性占 40.6%。通过全外显子组测序,在 99 个家系的 101 名患者中发现了 114 种不同的突变,其中 68 种为以前未报道过的突变。最常见的突变类型是甘氨酸取代,在 X 连锁 Alport 综合征、常染色体隐性和常染色体显性 Alport 综合征患者中分别占 52.1%、36.7%和 60%。在中位数为 3.3(1.8-6.3)年的随访结束时,Kaplan-Meier 曲线显示常染色体隐性遗传 Alport 综合征患者的肾脏存活率明显低于 X 连锁 Alport 综合征(P=0.004)。Alport 综合征的儿科患者很少出现肾外表现。
本队列中最常见的形式是 X 连锁 Alport 综合征。常染色体隐性遗传比 X 连锁 Alport 综合征的进展更快。